FX.co ★ TransCode Appoints Daniel Vlock As CMO

TransCode Therapeutics, Inc. (RNAZ), a corporation specializing in cancer treatment through RNA therapeutics, recently revealed the appointment of Daniel Vlock as their chief medical officer. Vlock, a seasoned medical oncologist, brings over a quarter of a century of professional experience in the industry, coupled with 15 years in academia to the role.